0000950170-24-076705.txt : 20240624
0000950170-24-076705.hdr.sgml : 20240624
20240624160506
ACCESSION NUMBER: 0000950170-24-076705
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240620
FILED AS OF DATE: 20240624
DATE AS OF CHANGE: 20240624
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: THEUER CHARLES
CENTRAL INDEX KEY: 0001631338
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50549
FILM NUMBER: 241064242
MAIL ADDRESS:
STREET 1: C/O TRACON PHARMACEUTICALS, INC.
STREET 2: 4350 LA JOLLA VILLAGE DRIVE, SUITE 800
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc.
CENTRAL INDEX KEY: 0001260990
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 621715807
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 230
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 434-1113
MAIL ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 230
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: GTX INC /DE/
DATE OF NAME CHANGE: 20030822
4
1
ownership.xml
4
X0508
4
2024-06-20
0001260990
Oncternal Therapeutics, Inc.
ONCT
0001631338
THEUER CHARLES
12230 EL CAMINO REAL, SUITE 230
SAN DIEGO
CA
92130
true
false
false
false
false
Stock Options
8.10
2024-06-20
4
A
false
2200
0
A
2034-06-20
Common Stock
2200
2200
D
One-twelfth of the number of shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of the grant date, subject to the Reporting Person's continued service through such vesting date.
/s/Chase C. Leavitt, Attorney-in-fact
2024-06-24